INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 222 filers reported holding INSMED INC in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,122 | +78.2% | 1,589 | +48.9% | 0.01% | +28.6% |
| Q2 2023 | $22,514 | +68.0% | 1,067 | +35.8% | 0.01% | +75.0% |
| Q1 2023 | $13,401 | -56.7% | 786 | -49.3% | 0.00% | -60.0% |
| Q4 2022 | $30,969 | +674.2% | 1,550 | +747.0% | 0.01% | +400.0% |
| Q2 2022 | $4,000 | -99.0% | 183 | -98.9% | 0.00% | -99.0% |
| Q1 2022 | $408,000 | -10.5% | 17,355 | +3.6% | 0.20% | -3.3% |
| Q4 2021 | $456,000 | +6.8% | 16,745 | +7.8% | 0.21% | -22.6% |
| Q3 2021 | $427,000 | -5.1% | 15,527 | -1.9% | 0.27% | -3.2% |
| Q2 2021 | $450,000 | +14900.0% | 15,822 | +18514.1% | 0.28% | +5560.0% |
| Q1 2021 | $3,000 | – | 85 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
| Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
| Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
| Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
| NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
| Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
| Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
| Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
| Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
| EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |